Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease

Nucleic acid-based technologies have received significant interest in recent years as novel theranostic strategies for various diseases. The approval by the United States Food and Drug Administration (FDA) of Nusinersen, an antisense oligonucleotide drug, for the treatment of spinal muscular dystrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakravarthy, Madhuri, Chen, Suxiang, Dodd, Peter R., Veedu, Rakesh N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667416/
https://www.ncbi.nlm.nih.gov/pubmed/29109789
http://dx.doi.org/10.7150/thno.21529

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667416/
https://www.ncbi.nlm.nih.gov/pubmed/29109789
http://dx.doi.org/10.7150/thno.21529

Ejemplares similares